Match tier
Likely match
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-10
M
Meloney D. Cregor
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Purdue University West Lafayette (1990–1992); Central Arkansas Veterans Healthcare System (2023–2026); Richard L. Roudebush VA Medical Center (2024); Bioanalytical Systems (United States) (2000–2002); John L. McClellan Memorial Veterans Hospital (2023–2026); Indiana University Indianapolis (2015–2024); Indiana University School of Medicine (2015–2025); Indiana University – Purdue University Indianapolis (2017)
16 h-index
52 pubs
1,005 cited
Biomedical Subjects
Biography and Research Information
Metrics
- h-index: 16
- Publications: 52
- Citations: 1,005
Selected Publications
-
DMP1-Cre expressing cells mediate the gain in bone mass and strength, but not the increase in bone remodeling, induced by ligands of the parathyroid hormone receptor (2026)
-
Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease (2024)
-
Abaloparatide is more potent than teriparatide in restoring bone mass and strength in type 1 diabetic male mice (2024)
-
OR29-04 Vitamin D Signaling Prevents Glucocorticoid-Induced Musculoskeletal Tissue Loss And Cardiac Dysfunction By Targeting The Atrogene Pathway (2023)
-
THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies (2023)
-
Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice (2023)
-
Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice (2023)
-
Reversal of the diabetic bone signature with anabolic therapies in mice (2023)
-
Data from Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity (2023)
-
Abstract 5672: Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction (2022)
-
Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction (2022)
-
Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity (2021)
-
Skeletal Protection and Promotion of Microbiome Diversity by Dietary Boosting of the Endogenous Antioxidant Response (2020)